Healthcare

A European aesthetics company designed to capitalize on changing consumers, advances in technology, and demand for more affordable treatments

More than 11 million Americans over the age of 50 are affected by debilitating midfoot osteoarthritis, now there’s a solution

abioSCOPE® is point-of-care platform that measures a biomarker that may begin rising 48 to 72 hours before a clinical diagnosis for sepsis

OneTest measures established protein tumor markers and uses machine learning to identify patterns associated with multiple cancers.

Beren Therapeutics is developing a new class of medicines targeting numerous neurodegenerative diseases, including Alzheimer’s.

A new therapeutic modality designed to directly target and destroy disease gene sequences rather than simply treat the symptoms of a disease

HDT Bio is developing a new immune-maintenance therapy for breast cancer patients designed to prevent relapse years after successful treatment.

A first-in-class oral therapy for cancer, neuroinflammatory, and autoimmune disease with both FDA Fast Track and Orphan Drug designations

OneTest measures established protein tumor markers and uses machine learning to identify patterns associated with multiple cancers.